OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (362)	2/8/2006 1:17:12 PM
From: former_pgs	Read Replies (1) of 447

I agree with your thoughts. What's even more scary about the cell pathways acquisition (foreshadowing?) is that at the time, cell pathways had a silly little oral gel product (gelclair) approved to treat mucositis. Goddard thought he could get back the money he spent on clpa simply from gelclair sales, leaving the remaining technology free to the company. Suffice to say, Goddard couldn't sell the product. No one can. And now he just bought another product that he thinks he can easily sell to recover the money he spent. Given the nice pocket cards he has been given as CEO, Goddard has seriously screwed up the rest of the hand.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next